Panagiotopoulos, E.; Palaiodimou, L.; Theodorou, A.; Papagiannopoulou, G.; Bakola, E.; Chondrogianni, M.; Psychogios, K.; Kargiotis, O.; Safouris, A.; Vlachopoulos, C.;
et al. Lipoprotein(a) as a Stroke Biomarker: Pathophysiological Pathways and Therapeutic Implications. J. Clin. Med. 2025, 14, 2990.
https://doi.org/10.3390/jcm14092990
AMA Style
Panagiotopoulos E, Palaiodimou L, Theodorou A, Papagiannopoulou G, Bakola E, Chondrogianni M, Psychogios K, Kargiotis O, Safouris A, Vlachopoulos C,
et al. Lipoprotein(a) as a Stroke Biomarker: Pathophysiological Pathways and Therapeutic Implications. Journal of Clinical Medicine. 2025; 14(9):2990.
https://doi.org/10.3390/jcm14092990
Chicago/Turabian Style
Panagiotopoulos, Evangelos, Lina Palaiodimou, Aikaterini Theodorou, Georgia Papagiannopoulou, Eleni Bakola, Maria Chondrogianni, Klearchos Psychogios, Odysseas Kargiotis, Apostolos Safouris, Charalambos Vlachopoulos,
and et al. 2025. "Lipoprotein(a) as a Stroke Biomarker: Pathophysiological Pathways and Therapeutic Implications" Journal of Clinical Medicine 14, no. 9: 2990.
https://doi.org/10.3390/jcm14092990
APA Style
Panagiotopoulos, E., Palaiodimou, L., Theodorou, A., Papagiannopoulou, G., Bakola, E., Chondrogianni, M., Psychogios, K., Kargiotis, O., Safouris, A., Vlachopoulos, C., Giannopoulos, S., Themistocleous, M., Lambadiari, V., Tsivgoulis, G., & Stefanou, M.-I.
(2025). Lipoprotein(a) as a Stroke Biomarker: Pathophysiological Pathways and Therapeutic Implications. Journal of Clinical Medicine, 14(9), 2990.
https://doi.org/10.3390/jcm14092990
